LINC01732

Across TCGA pan-cancer cohorts, LINC01732 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC01732’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01732 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01732 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.

KIRC, LUSC, and THCA are the cancer types where LINC01732 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01732 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	+0.180	<.001	12	view →
LUSC	All	II,III,IV	−0.499	<.001	8	view →
THCA	All	All	+0.144	<.001	8	view →
LIHC	Male	All	+0.155	.008	5	view →
LUAD	All	All	−0.313	<.001	4	view →
HNSC	Male	II,III,IV	+0.115	.012	3	view →
UCEC	All	All	−0.569	.005	2	view →
BLCA	All	All	+0.225	.030	2	view →
PRAD	All	All	−0.026	.046	2	view →
CHOL	All	All	+0.139	.032	1	view →
STAD	All	IV	+0.103	.001	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC01732–KIRC

Open the KIRC breakdown →